Call Options Transactions Made in Q3 2022 in Neurocrine Biosciences Inc (NBIX)
This table provides information about the institutional ownership of Neurocrine Biosciences Inc (NBIX) during Q3 2022. The information is specifically focused on institutions that hold call options of NEUROCRINE BIOSCIENCES INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 14, 2022
Q3 2022
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
CALL |
26K+ 68.78% |
$2.39M - $2.8M
|
63.8K
$8.64M
|
|
Nov 10, 2022
Q3 2022
|
Citigroup Inc
|
BUY
|
CALL |
17.7K+ 1361.54% |
$1.63M - $1.91M
|
19K
$2.57M
|
|
Nov 14, 2022
Q3 2022
|
Caption Management, LLC
Oklahoma City, OK |
SELL
|
CALL |
-26.4K- 48.0% |
$2.43M - $2.85M
|
28.6K
$3.87M
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
CALL |
-42.2K- 58.61% |
$3.88M - $4.55M
|
29.8K
$4.04M
|
|
Nov 15, 2022
Q3 2022
|
Nomura Holdings Inc
Tokyo, M0 |
SELL
|
CALL |
-44.7K- 49.89% |
$4.11M - $4.82M
|
44.9K
$6.08M
|